DK1906931T3 - Forberedt farmaceutisk præparat, de indeholder ACE-inhibitor og fremgangsmåde til fremstilling deraf - Google Patents

Forberedt farmaceutisk præparat, de indeholder ACE-inhibitor og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1906931T3
DK1906931T3 DK06765392T DK06765392T DK1906931T3 DK 1906931 T3 DK1906931 T3 DK 1906931T3 DK 06765392 T DK06765392 T DK 06765392T DK 06765392 T DK06765392 T DK 06765392T DK 1906931 T3 DK1906931 T3 DK 1906931T3
Authority
DK
Denmark
Prior art keywords
preparation
ace inhibitor
pharmaceutical composition
prepared pharmaceutical
contain
Prior art date
Application number
DK06765392T
Other languages
Danish (da)
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Evangelos Kotzagiorgis
Dimitrios Bikiaris
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Application granted granted Critical
Publication of DK1906931T3 publication Critical patent/DK1906931T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06765392T 2005-06-30 2006-06-29 Forberedt farmaceutisk præparat, de indeholder ACE-inhibitor og fremgangsmåde til fremstilling deraf DK1906931T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20050100332A GR1006875B (el) 2005-06-30 2005-06-30 Βελτιωμενες φαρμακευτικες συνθεσεις περιεχουσες αναστολεις του μετατρεπτικου ενζυμου αγγειοτενσινης και μεθοδοι παρασκευης αυτων.
PCT/GR2006/000033 WO2007003972A1 (fr) 2005-06-30 2006-06-29 Composition pharmaceutique amelioree contenant un inhibiteur ace et procede de preparation de ladite composition

Publications (1)

Publication Number Publication Date
DK1906931T3 true DK1906931T3 (da) 2009-03-09

Family

ID=38043070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06765392T DK1906931T3 (da) 2005-06-30 2006-06-29 Forberedt farmaceutisk præparat, de indeholder ACE-inhibitor og fremgangsmåde til fremstilling deraf

Country Status (12)

Country Link
EP (1) EP1906931B1 (fr)
AT (1) ATE415951T1 (fr)
CA (1) CA2612742C (fr)
CY (1) CY1108846T1 (fr)
DE (1) DE602006004057D1 (fr)
DK (1) DK1906931T3 (fr)
ES (1) ES2318772T3 (fr)
GR (1) GR1006875B (fr)
HR (1) HRP20090102T3 (fr)
PL (1) PL1906931T3 (fr)
PT (1) PT1906931E (fr)
WO (1) WO2007003972A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN114886866A (zh) * 2022-04-08 2022-08-12 苏州中化药品工业有限公司 一种格列齐特片(ⅱ)药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA2019324C (fr) * 1989-07-10 1996-08-20 Robert L. Jerzewski Comprimes de fosinopril
JP2002535353A (ja) * 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物

Also Published As

Publication number Publication date
ATE415951T1 (de) 2008-12-15
CY1108846T1 (el) 2014-07-02
HRP20090102T3 (en) 2009-03-31
GR1006875B (el) 2010-07-12
DE602006004057D1 (de) 2009-01-15
CA2612742C (fr) 2010-08-03
CA2612742A1 (fr) 2007-01-11
PT1906931E (pt) 2009-02-12
PL1906931T3 (pl) 2009-05-29
WO2007003972A1 (fr) 2007-01-11
EP1906931A1 (fr) 2008-04-09
ES2318772T3 (es) 2009-05-01
GR20050100332A (el) 2007-01-19
EP1906931B1 (fr) 2008-12-03

Similar Documents

Publication Publication Date Title
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
NO20084256L (no) DPP IV inhibitorformuleringer
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
WO2009121872A3 (fr) Tétrahydroisoquinoléines, compositions pharmaceutiques les contenant et leur utilisation en thérapie
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
WO2009024611A3 (fr) 4-benzylaminoquinoléines, compositions pharmaceutiques les contenant, et leur utilisation en thérapie
UA99136C2 (ru) Улучшенная фармацевтическая композиция, содержащая антагонист кальциевых каналов - лерканидипин, способ ее получения
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
TW200626158A (en) Naphthaline derivatives
WO2008062476A3 (fr) Composition pharmaceutique comprenant de la rosuvastatine ou un sel de qualité pharmaceutique de cette substance
UA116334C2 (uk) Тверді форми дозування бендамустину
CY1112702T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει εναν αντισπασμωδικο παραγοντα πυρρολιδονης και μεθοδος για την παρασκευη της
GR1006879B (el) Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουν αναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
DK1906931T3 (da) Forberedt farmaceutisk præparat, de indeholder ACE-inhibitor og fremgangsmåde til fremstilling deraf
IL191670A0 (en) Compounds for the inhibition of apoptosis
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
GB0620619D0 (en) Novel compounds
WO2006129056A3 (fr) Nouveau sel et procede associe
CY1110563T1 (el) Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου
MY150480A (en) Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof